Sankarajyothi Ayurvedic And Herbals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 22-06-2024
- Paid Up Capital ₹ 0.50 M
as on 22-06-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 22-06-2024
- Revenue 42.40%
(FY 2022)
- Profit 131.45%
(FY 2022)
- Ebitda 281.88%
(FY 2022)
- Net Worth 3.86%
(FY 2022)
- Total Assets 14.15%
(FY 2022)
About Sankarajyothi Ayurvedic And Herbals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.50 M.
Divya Unni, Sooraj Rajan, Shini Sreedharan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233KL2008PTC023507
- Company No.
023507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2008
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Pathanamthitta, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sankarajyothi Ayurvedic And Herbals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shini Sreedharan  | Managing Director | 05-Dec-2008 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Divya Unni | Director | 16-Mar-2023 | Current |
| Sooraj Rajan | Director | 03-Sep-2018 | Current |
| Rajan Damodaran | Director | 05-Dec-2008 | Current |
Financial Performance and Corporate Structure Insights of Sankarajyothi Ayurvedic And Herbals.
Sankarajyothi Ayurvedic And Herbals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.4% increase. The company also saw a substantial improvement in profitability, with a 131.45% increase in profit. The company's net worth moved up by a moderate rise of 3.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sankarajyothi Ayurvedic And Herbals?
In 2020, Sankarajyothi Ayurvedic And Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
6 years 9 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 05 Feb 2009 | ₹2.50 M | Open |
How Many Employees Work at Sankarajyothi Ayurvedic And Herbals?
Unlock and access historical data on people associated with Sankarajyothi Ayurvedic And Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sankarajyothi Ayurvedic And Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sankarajyothi Ayurvedic And Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
